Delivery Order SPE2DB22D2206-SPE2DB24FFN92
- Not listed
- This is a $14,704.98 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ERLEADA 240 MG TABLET UU 30S. The contract has an ultimate completion date of July 29, 2025 and is a firm fixed price agreement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and...
- This is a firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, with a ceiling value of $7,352.49. The contract is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product, with a performance period through June 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This $7,306.27 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 120 tablets of the medication ERLEADA 60 MG, with a completion date of September 24, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to supply a comprehensive range of medical commodities to support military...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the provision of ERLEADA 60 MG TABLET UU 120S, a specialty pharmaceutical product, with a potential value of $8,709.64 and a completion date of March 27, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, for the supply of the drug Erleada (60 mg tablets) valued at $7,106.87. The award has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order, which does not have a set-aside designation. The company also holds a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $28,427.48, is for the supply of the pharmaceutical product ERLEADA 60 MG TABLET (NDC 57894-0620-12) with an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. Amerisourcebergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price contract is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a period of performance through February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, with a ceiling value of $7,558.78 and a completion date of June 3, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the supply of ERLEADA 60 MG TABLET UU 120S. The $7,106.87 fixed-price contract has a completion date of June 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025, as well as a smaller IDC with the Department of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ERLEADA 240 MG TABLET UU 30S. The contract has a firm fixed price of $7,352.49 and a period of performance through June 5, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFN92Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of ERLEADA 60 MG TABLET UU 120S. The order has a potential value of $34,838.56 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This particular order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.8k | 2/9/24 |